Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal decision profile

Angiogenesis

Biochemistry, Genetics and Molecular Biology · Medicine
Springer Science+Business MediaNetherlandspISSN 0969-6970eISSN 1573-7209
Checking system sharing availability.Visit homepage
Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
7.5

Journal Metrics Score 2026 · 2021–2024 window citedness 9.99.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
103 daysmedian

Middle 50%: 78–159 days

100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$4,890

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
7.52026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#129 / 609LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
38.8%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
2.11MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
103 daysIQR 78–159 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
50 / yr2021–2024 AVG
Field-normalized top 10% share38.8%

78 of 201 works · same type, year & subfield

Field-normalized top 1% share5.5%

11 works · same type, year & subfield

Median FWCI2.11×

Above field-year expectation

Source output rank#129

of 609 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 2.11, so its typical recent paper runs about 111% above its field benchmark.

What does Top 10% Share mean?

38.8% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

452016
482017
692018
452019
572020
652021
402022
362023
602024
642025

Recent work-type mix

201 OpenAlex works · 2021–2024

Article92%
Erratum7%
Letter0.5%
Retraction0.5%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works
Endothelial CellsNeovascularization, PhysiologicNeovascularization, PathologicCOVID-19ZebrafishNeoplasmsSignal TransductionArteriovenous MalformationsLymphangiogenesis

Leading OpenAlex topics

2021–2024 works
Angiogenesis and VEGF in Cancer26
Vascular Malformations Diagnosis and Treatment12
COVID-19 Clinical Research Studies9
Vascular Anomalies and Treatments8
Zebrafish Biomedical Research Applications8
Lymphatic System and Diseases7
Hippo pathway signaling and YAP/TAZ5
Long-Term Effects of COVID-195
3D Printing in Biomedical Research4
Cancer, Hypoxia, and Metabolism4
Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 201 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Recommended alternatives

Candidates share the leading OpenAlex topic, then subfield or field when needed, and are ranked by current Journal Metrics Score.

OpenAlex topic-neighbor model · Preview
Nature Reviews Molecular Cell BiologyTopic-neighbor alternative41.7Metrics Score—Submission → acceptance$—Cost*CellTopic-neighbor alternative39.2Metrics Score296dIQR 208–426dSubmission → acceptance$$$Cost*Annual Review of Pathology-Mechanisms of DiseaseTopic-neighbor alternative22.3Metrics Score—Submission → acceptance$—Cost*ImetaTopic-neighbor alternative22.0Metrics Score48dIQR 29–85dSubmission → acceptance$—Cost*Physiological ReviewsTopic-neighbor alternative20.8Metrics Score—Submission → acceptance$—Cost*Journal of Extracellular VesiclesTopic-neighbor alternative19.5Metrics Score190dIQR 143–233dSubmission → acceptance$$$Cost*

More alternative journals

Nature ProtocolsBone ResearchCell Stem CellNature ChemistryNature Reviews GeneticsNature Communications

* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Molecular BiologyQ1
Cancer ResearchQ1
Immunology and AllergyQ1
OncologyQ1

Considering submitting to Angiogenesis?

Use your manuscript title to find AI-ranked journals with related recent work, fit reasons, risks, and submission strategy.

Match my manuscript →
Q1
Subfield Quartile
B1
CAS Block

Ranking and source check

#57
of 853 Oncology field journals
#57
among Q1 Oncology journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

View all Oncology journals →View Q1 Oncology journals →

Journal Details

OpenAlex Works
1,497
H-Index
124
Fully Open Access
No
Recent OA Works
581
Subject Areas
Molecular BiologyCancer ResearchImmunology and AllergyOncology

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

Related Guides

Field Rankings
Best Oncology Journals: Journal Metrics Scores and Cancer Research Guide
12 min read
Field Rankings
Archived Chemistry Journal Selection Guide
14 min read
Field Rankings
Archived Biology Journal Selection Guide
14 min read
Field Rankings
Archived Medical Journal Selection Guide
14 min read
Back to Search